Michael Landsittel

CIK 1651036 · Chief Financial Officer · last filed 2026-03-25

Michael Landsittel is a Chief Financial Officer who has filed 24 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing, for DMRA, was dated Mar 25, 2026. Across all open-market trades the lifetime net is −$4.9M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

24

Lifetime Open-Market Net

-$4.91M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
DMRA Director $20.78 $0 1 2026-03-25
Blueprint Medicines Corp (BPMC) Delisted Chief Financial Officer 94,277 $129.46 $12.21M -$4.91M 23 2025-07-21

Recent Filings

24 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-03-25 DMRA Grant (A) $0 EDGAR
2025-07-21 Blueprint Medicines Corp (BPMC) Delisted Mixed −72,924 $0 EDGAR
2025-03-07 Blueprint Medicines Corp (BPMC) Delisted Sell (S) −5,284 -$469.2K EDGAR
2025-03-04 Blueprint Medicines Corp (BPMC) Delisted Grant (A) +11,000 $0 EDGAR
2024-08-19 Blueprint Medicines Corp (BPMC) Delisted Sell (S) −4,409 -$419.9K EDGAR
2024-05-17 Blueprint Medicines Corp (BPMC) Delisted Sell (S) −3,850 -$411.8K EDGAR
2024-05-10 Blueprint Medicines Corp (BPMC) Delisted Exer (M) +28,181 $65.3K EDGAR
2024-05-06 Blueprint Medicines Corp (BPMC) Delisted Mixed -$689.5K EDGAR
2024-04-01 Blueprint Medicines Corp (BPMC) Delisted Mixed -$294.8K EDGAR
2024-03-19 Blueprint Medicines Corp (BPMC) Delisted Mixed −8,734 -$1.03M EDGAR
Showing 110 of 24
Page 1 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.